Bellicum Pharmaceuticals, Inc. Return on Tangible Equity 2015-2023 | BLCM

Current and historical return on tangible equity values for Bellicum Pharmaceuticals, Inc. (BLCM) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2023-09-30 $-0.02B $0.01B -204.65%
2023-06-30 $-0.03B $0.01B -175.00%
2023-03-31 $-0.03B $0.01B -109.89%
2022-12-31 $-0.03B $0.02B -88.50%
2022-09-30 $-0.02B $0.03B -47.41%
2022-06-30 $-0.01B $0.03B -27.83%
2022-03-31 $-0.01B $0.04B -27.59%
2021-12-31 $-0.01B $0.04B -63.16%
2021-09-30 $0.02B $0.01B 245.16%
2021-06-30 $0.02B $0.00B -3400.00%
2021-03-31 $-0.02B $0.01B 290.91%
2020-12-31 $-0.01B $0.02B 133.33%
2020-09-30 $-0.07B $-0.03B 604.44%
2020-06-30 $-0.10B $-0.03B -7920.00%
2020-03-31 $-0.08B $0.01B -535.48%
2019-12-31 $-0.11B $-0.01B -456.57%
2019-09-30 $-0.11B $0.02B -258.14%
2019-06-30 $-0.10B $0.03B -170.95%
2019-03-31 $-0.10B $0.05B -123.46%
2018-12-31 $-0.10B $0.07B -115.63%
2018-09-30 $-0.09B $0.09B -104.49%
2018-06-30 $-0.09B $0.11B -100.27%
2018-03-31 $-0.09B $0.07B -97.61%
2017-12-31 $-0.09B $0.09B -80.18%
2017-09-30 $-0.09B $0.10B -76.39%
2017-06-30 $-0.08B $0.12B -70.59%
2017-03-31 $-0.08B $0.14B -64.17%
2016-12-31 $-0.07B $0.10B -58.70%
2016-09-30 $-0.07B $0.11B -50.38%
2016-06-30 $-0.06B $0.13B -42.39%
2016-03-31 $-0.06B $0.14B -35.28%
2015-12-31 $-0.05B $0.15B -28.82%
2015-09-30 $-0.11B $0.17B -58.89%
2015-06-30 $-0.10B $0.18B -70.04%
2015-03-31 $-0.09B $0.19B -95.49%
2014-12-31 $-0.09B $0.19B -177.08%